Overview |
bs-9915R-RBITC |
Orosomucoid 2 Polyclonal Antibody, RBITC Conjugated |
WB, IF(IHC-P) |
Human |
Specifications |
RBITC |
Rabbit |
KLH conjugated synthetic peptide derived from human Orosomucoid 2 |
101-201/201 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
5005 |
Orosomucoid-2; AGP 2; AGP-2; AGP B; AGP-B; AGP2; Alpha 1 acid glycoprotein 2; Alpha 1 acid glycoprotein type 2; OMD 2; OMD2; OMD-2; ORM 2; ORM2; ORM-2; Orosomucoid2; A1AG2_HUMAN. |
Orosomucoid 2 is a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however Orosomucoid 2 appears to function in modulating the activity of the immune system during the acute-phase reaction. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |